Consun Pharma (01681) announced that on September 15, 2026, it spent approximately 3.99 million Hong Kong dollars to repurchase 301,000 of its own shares.
The buyback was executed at a per-share price ranging from 13.16 to 13.29 Hong Kong dollars, according to the company's official filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.